Navigation Links
Consensus on "Combination Therapy" for Breast Cancer ,,

Breast cancer is the commonest cancer among women in the world. There has been some on going controversy on certain aspects of treatment modalities of this cancer. Besides surgery there are other options to treat the cancer including radiation, chemotherapy and hormonal therapy. Now at a three-day conference at the National Institutes of Health doctors have agreed to a consensus on the combination therapy for the cancer. Dctors have agreed that the combination therapy for women with breast cancer is beneficial. Depending on a woman's stage of the disease the experts recommend surgery along with either chemotherapy or hormonal therapy.



To help in the decision-making, experts came up with their own recommendations as follows:

1. Women whose breast tumors contain estrogen receptors, regardless of other factors, are recommended to use hormonal therapy. The panel suggests five years of drug-Tamoxifen as the standard hormonal adjuvant therapy. Hormonal therapy is not suggested for women whose tumors do not have hormone receptors.

2. Women who have had a mastectomy and have four or more cancerous lymph nodes can best benefit from post-surgical radiation. At this point the panel says there is not enough evidence that women with three or fewer cancerous lymph nodes benefit from radiation.

Patricia Eifel of Anderson Cancer Center in Houston, said to one of the medical news agencies that, "Women with breast cancer have more treatment options and a better chance of surviving their disease than ever before. At the same time, making treatment decisions has become a more complex process for them and their physicians due to a growing list of effective options."
'"/>




Page: 1

Related medicine news :

1. Climate Talks Reach Consensus in Bangkok
2. Women Alerted against "Natural Hormone Replacement Therapy"
3. Breast cancer treatment to be determined by gene test
4. Breast Feeding prevents obesity later on in life
5. Breast milk is essential
6. Breast Cancer Surgery Causes Psychological problems
7. Breast cancer evidence
8. Letrozole Beats Tamoxifen in Breast Cancer Therapy
9. Breast screening among diabetic women
10. Breast feeding can alter hormones
11. Diet, Sunlight connected to Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: